Transitional community adherence support for people leaving incarceration in South Africa: a pragmatic, open-label, randomised controlled trial

被引:1
|
作者
Mabuto, Tonderai [1 ,9 ]
Woznica, Daniel M. [2 ]
Ndini, Pretty [1 ]
Moyo, Derrick
Abraham, Munazza [3 ]
Hanrahan, Colleen [6 ]
Charalambous, Salome [1 ,4 ]
Zack, Barry [5 ]
Baral, Stefan [6 ]
Owczarzak, Jill [7 ]
Hoffmann, Christopher J. [4 ,8 ]
机构
[1] Aurum Inst, Dept Implementat Res, Johannesburg, South Africa
[2] Soc Crit Care Med, Mt Prospect, IL USA
[3] Univ Maryland, Dept Psychol, College Pk, MD USA
[4] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa
[5] Bridging Grp, Oakland, CA USA
[6] Johns Hopkins Univ, Sch Med, Dept Epidemiol, Baltimore, MD USA
[7] Johns Hopkins Univ, Sch Med, Dept Hlth Behav & Soc, Baltimore, MD USA
[8] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[9] Aurum Inst, Dept Implementat Res, ZA-2197 Johannesburg, South Africa
来源
LANCET HIV | 2024年 / 11卷 / 01期
关键词
HIV CARE CONTINUUM; PRISON; RELEASE; IMPROVE;
D O I
10.1016/S2352-3018(23)00235-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background People released from correctional facilities face multifactorial barriers to continuing HIV treatment. We hypothesised that barriers faced in the first 6 months of community re-entry would be decreased by a multilevel group-based and peer-led intervention, the Transitional Community Adherence Club (TCAC). Methods We did a pragmatic, open-label, individually randomised controlled trial in five correctional facilities in Gauteng, South Africa. Participants aged 18 years and older and receiving antiretroviral therapy (ART) in correctional facilities were enrolled before release and randomly assigned (1:2) to either passive referral (usual care) or TCACs. TCACs followed a 12-session curriculum over 6 months and were facilitated by trained peer and social workers. Participants were followed up by telephone and in person to assess the primary outcome: post-release enrolment in HIV treatment services at 6 months from the date of release. We did an intention-to-treat analysis to determine the effectiveness of TCACs compared with usual care. The trial was registered with the South African National Clinical Trials Register (DOH-27-0419-605) and ClinicalTrials.gov (NCT03340428). This study is completed and is listed as such on ClinicalTrials.gov. Findings From March 1, to Dec 13, 2019, we screened 222 individuals and enrolled 176 participants who were randomly assigned 1:2 to the usual care group (n=59) or TCACs (n=117). 175 participants were included in the final analysis. In the usual care group, 21 (36%) of 59 participants had enrolled in HIV treatment services at 6 months, compared with 71 (61%) of 116 in the TCAC group (risk ratio 1 center dot 7, 95% CI 1 center dot 2-2 center dot 5; p=0 center dot 0010). No adverse events were reported. Interpretation We found strong evidence that a differentiated service delivery model with curriculum and peer support designed specifically to address the needs of people with HIV returning from incarceration improved the primary outcome of enrolment in HIV treatment services. Our approach is a reasonable model to build further HIV treatment continuity interventions for individuals in the criminal justice system in South Africa and elsewhere.
引用
收藏
页码:e11 / e19
页数:9
相关论文
共 50 条
  • [1] Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
    Mfinanga, Sayoki
    Chanda, Duncan
    Kivuyo, Sokoine L.
    Guinness, Lorna
    Bottomley, Christian
    Simms, Victoria
    Chijoka, Carol
    Masasi, Ayubu
    Kimaro, Godfather
    Ngowi, Bernard
    Kahwa, Amos
    Mwaba, Peter
    Harrison, Thomas S.
    Egwaga, Saidi
    Jaffar, Shabbar
    LANCET, 2015, 385 (9983): : 2173 - 2182
  • [2] Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
    Iwuji, Collins C.
    Orne-Gliemann, Joanna
    Larmarange, Joseph
    Balestre, Eric
    Thiebaut, Rodolphe
    Tanser, Frank
    Okesola, Nonhlanhla
    Makowa, Thembisa
    Dreyer, Jaco
    Herbst, Kobus
    McGrath, Nuala
    Barnighausen, Till
    Boyer, Sylvie
    De Oliveira, Tulio
    Rekacewicz, Claire
    Bazin, Brigitte
    Newell, Marie-Louise
    Pillay, Deenan
    Dabis, Francois
    LANCET HIV, 2018, 5 (03): : E116 - E125
  • [3] Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
    Naslund, Ulf
    Ng, Nawi
    Lundgren, Anna
    Fharm, Eva
    Gronlund, Christer
    Johansson, Helene
    Lindahl, Bernt
    Lindahl, Bertil
    Lindvall, Kristina
    Nilsson, Stefan K.
    Nordin, Maria
    Nordin, Steven
    Nyman, Emma
    Rocklov, Joacim
    Vanoli, Davide
    Weinehall, Lars
    Wennberg, Patrik
    Wester, Per
    Norberg, Margareta
    LANCET, 2019, 393 (10167): : 133 - 142
  • [4] Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial
    Hallifax, Rob J.
    McKeown, Edward
    Sivakumar, Parthipan
    Fairbairn, Ian
    Peter, Christy
    Leitch, Andrew
    Knight, Matthew
    Stanton, Andrew
    Ijaz, Asim
    Marciniak, Stefan
    Cameron, James
    Bhatta, Amrithraj
    Blyth, Kevin G.
    Reddy, Raja
    Harris, Marie-Clare
    Maddekar, Nadeem
    Walker, Steven
    West, Alex
    Laskawiec-Szkonter, Magda
    Corcoran, John P.
    Gerry, Stephen
    Roberts, Corran
    Harvey, John E.
    Maskell, Nick
    Miller, Robert F.
    Rahman, Najib M.
    LANCET, 2020, 396 (10243): : 39 - 49
  • [5] Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial
    Hallifax, Rob
    Laskawiec-Szkonter, Magda
    Dobson, Melissa
    Gerry, Stephen
    Miller, Robert F.
    Harvey, John E.
    Rahman, Najib
    BMJ OPEN RESPIRATORY RESEARCH, 2019, 6 (01)
  • [7] Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
    Eikelboom, John W.
    Jolly, Sanjit S.
    Belley-Cote, Emilie P.
    Whitlock, Richard P.
    Rangarajan, Sumathy
    Xu, Lizhen
    Heenan, Laura
    Bangdiwala, Shrikant, I
    Tarhuni, Wadea M.
    Hassany, Mohamed
    Kontsevaya, Anna
    Harper, William
    Sharma, Sanjib Kumar
    Lopez-Jaramillo, Patricio
    Dans, Antonio L.
    Palileo-Villanueva, Lia M.
    Avezum, Alvaro
    Pais, Prem
    Xavier, Denis
    Felix, Camilo
    Yusufali, Afzalhussein
    Lopes, Renato D.
    Berwanger, Otavio
    Ali, Zeeshan
    Wasserman, Sean
    Anand, Sonia S.
    Bosch, Jackie
    Choudhri, Shurjeel
    Farkouh, Michael E.
    Loeb, Mark
    Yusuf, Salim
    LANCET RESPIRATORY MEDICINE, 2022, 10 (12): : 1160 - 1168
  • [8] Superiority and cost-effectiveness of Individual Placement and Support versus standard employment support for people with alcohol and drug dependence: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
    Marsden, John
    Anders, Paul
    Shaw, Claire
    Amasiatu, Chioma
    Collate, Winnie
    Eastwood, Brian
    Horgan, Patrick
    Khetani, Meetal
    Knight, Jonathan
    Knight, Sandy
    Melaugh, Alexandra
    Clark, Helen
    Stannard, Jez
    ECLINICALMEDICINE, 2024, 68
  • [9] The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial
    Westendorp, Willeke F.
    Vermeij, Jan-Dirk
    Zock, Elles
    Hooijenga, Imke J.
    Kruyt, Nyika D.
    Bosboom, Hans J. L. W.
    Kwa, Vincent I. H.
    Weisfelt, Martijn
    Remmers, Michel J. M.
    ten Houten, Robert
    Schreuder, A. H. C. M.
    Vermeer, Sarah E.
    van Dijk, Ewout J.
    Dippel, Diederik W. J.
    Dijkgraaf, Marcel G. W.
    Spanjaard, Lodewijk
    Vermeulen, Marinus
    van der Poll, Tom
    Prins, Jan M.
    Vermeij, Frederique H.
    Roos, Yvo B. W. E. M.
    Kleyweg, Ruud P.
    Kerkhoff, Henk
    Brouwer, Matthijs C.
    Zwinderman, Aeilko H.
    van de Beek, Diederik
    Nederkoorn, Paul J.
    LANCET, 2015, 385 (9977): : 1519 - 1526
  • [10] Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial
    Rich, Josiah D.
    McKenzie, Michelle
    Larney, Sarah
    Wong, John B.
    Tran, Liem
    Clarke, Jennifer
    Noska, Amanda
    Reddy, Manasa
    Zaller, Nickolas
    LANCET, 2015, 386 (9991): : 350 - 359